REFLOTRON HEMOGLOBIN 30 10744964203

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 01,05,06,07 report with the FDA on 2011-03-14 for REFLOTRON HEMOGLOBIN 30 10744964203 manufactured by Roche Diagnostics.

Event Text Entries

[9120738] One vial of test strips was returned by the customer for investigation. The customer's materials and retention samples were tested and were found to be within specification. All measurements gave results within specified ranges. Internal capillary blood testing revealed the quality of the batches used during testing were within specification. No malfunction was detected. Since the investigation showed the material met specification, it was recommended the customer check sample collection and preparation as outlined in the package insert. No adverse events were reported associated with this issue.
Patient Sequence No: 1, Text Type: N, H10


[17959527] This event occurred in (b)(6).
Patient Sequence No: 1, Text Type: N, H10


[17977870] The customer conducted pulic health care profiles at different locations several different days during a period of several weeks. The health profiles included glucose, cholesterol and hemoglobin testing. The participants were females (b)(6) and males (b)(6). The total number of participants was not provided. The customer provided 39 patient results tested in three different cities using the same hemoglobin strip lot number 20332603. Hemoglobin results from three of the participants were discrepant. Participant 1, male, initial result was <50 g/l. The participant was tested two more times. The first repeat result was >200 g/l. The second repeat result was 165 g/l. Participant 2, initial result was >200 g/l. The repeat results were >200 and 157 g/l. The date of testing was not provided. Participant 3, initial result was was >200 g/l. The repeat results were >200 g/l and 176 g/l. The date of testing was not provided. The participants were recommended to visit there ordinary health care provider for further investigation. No adverse events have been alleged regarding the discrepancies.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1823260-2011-01378
MDR Report Key2018224
Report Source01,05,06,07
Date Received2011-03-14
Date of Report2011-05-20
Date of Event2011-02-10
Date Mfgr Received2011-02-18
Date Added to Maude2011-03-14
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location3
Manufacturer ContactNA RICHEAL CLINE
Manufacturer Street9115 HAGUE ROAD NA
Manufacturer CityINDIANAPOLIS IN 46250
Manufacturer CountryUS
Manufacturer Postal46250
Manufacturer Phone3175213833
Manufacturer G1ROCHE DIAGNOSTICS GMBH
Manufacturer StreetSANDHOFERSTRASSE 116 NA
Manufacturer CityMANNHEIM (BADEN-WURTTEMBERG) 68305
Manufacturer Postal Code68305
Single Use3
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Details

Brand NameREFLOTRON HEMOGLOBIN 30
Generic NameWHOLE BLOOD HEMOGLOBIN DETERMINATION
Product CodeKHG
Date Received2011-03-14
Returned To Mfg2011-03-02
Model NumberNA
Catalog Number10744964203
Lot Number20332603
ID NumberNA
OperatorPHARMACIST
Device AvailabilityR
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerROCHE DIAGNOSTICS
Manufacturer Address9115 HAGUE ROAD NA INDIANAPOLIS IN NA US NA


Patients

Patient NumberTreatmentOutcomeDate
10 2011-03-14

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.